SangminLeeMD

PubMed

• 12 citations
  North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need.
  Naveen Pemmaraju, Hagop Kantarjian, Kendra Sweet, Eunice Wang, Jayastu Senapati, Nathaniel R Wilson, Marina Konopleva, Arthur E Frankel, Vikas Gupta, Ruben Mesa, Matth...> ;Blood. 2023 Feb 9
• 36 citations
  Olutasidenib alone or with azacitidine in IDH1-mutated acute myeloid leukaemia and myelodysplastic syndrome: phase 1 results of a phase 1/2 trial.
  Justin M Watts, Maria R Baer, Jay Yang, Thomas Prebet, Sangmin Lee, Gary J Schiller, Shira N Dinner, Arnaud Pigneux, Pau Montesinos, Eunice S Wang, Karen P Seiter, And...> ;The Lancet. Haematology. 2023 Jan 1
• 7 citations
  Oral eltanexor treatment of patients with higher-risk myelodysplastic syndrome refractory to hypomethylating agents.
  Sangmin Lee, Sanjay Mohan, Jessica Knupp, Kamal Chamoun, Adrienne de Jonge, Fan Yang, Erkan Baloglu, Jatin Shah, Michael G Kauffman, Sharon Shacham, Bhavana Bhatnagar> ;Journal of Hematology & Oncology. 2022 Aug 3
• 2 citations
  Synthesis ofI-labeled epichaperome probes and assessment in visualizing pathologic protein-protein interaction networks in tumor bearing mice.
  Sahil Sharma, Teja Kalidindi, Suhasini Joshi, Chander S Digwal, Palak Panchal, Eva Burnazi, Sang Gyu Lee, Nagavarakishore Pillarsetty, Gabriela Chiosis> ;STAR Protocols. 2022 Jun 17
• 2 citations
  Regulated interaction of ID2 with the anaphase-promoting complex links progression through mitosis with reactivation of cell-type-specific transcription.
  Sang Bae Lee, Luciano Garofano, Aram Ko, Fulvio D'Angelo, Brulinda Frangaj, Danika Sommer, Qiwen Gan, KyeongJin Kim, Timothy Cardozo, Antonio Iavarone, Anna Lasorella> ;Nature Communications. 2022 Apr 19
• 15 citations
  Chemical tools for epichaperome-mediated interactome dysfunctions of the central nervous system.
  Alexander Bolaender, Danuta Zatorska, Huazhong He, Suhasini Joshi, Sahil Sharma, Chander Singh Digwal, Hardik J. Patel, Weilin Sun, Brandon S Imber, Stefan O. Ochiana,...> ;Nature Communications. 2021 Aug 3
• 18 citations
  Accuracy of surface-guided patient setup for conventional radiotherapy of brain and nasopharynx cancer.
  Sangkyu Lee, Sheng Huang, Lei Zhang, Åse Ballangrud, Michalis Aristophanous, Laura I. Cervino Arriba, Guang Li> ;Journal of Applied Clinical Medical Physics. 2021 Mar 31
• 14 citations
  A dose escalation study of RO6870810/TEN-10 in patients with acute myeloid leukemia and myelodysplastic syndrome.
  Gail J. Roboz, Pinkal Desai, Sangmin Lee, Ellen K. Ritchie, Eric S. Winer, Mark DeMario, Barbara J. Brennan, Eveline Nüesch, Evelyne Chesne, Laura Brennan, Katharina L...> ;Leukemia & Lymphoma. 2021 Feb 13
• 2 citations
  Phase II study of the clinical efficacy and safety of tosedostat in patients with myelodysplastic syndromes (MDS) after failure of hypomethylating agent-based therapy.
  Sangmin Lee, Pinkal Desai, Bianca Edirisinghe, Tania J. Curcio, Michael Samuel, Ellen K. Ritchie, Gail J. Roboz, Samantha Pianello> ;Leukemia & Lymphoma. 2021 Jan 28
• 6 citations
  Comparison of Multiple Clinical Testing Modalities for Assessment of NPM1-Mutant AML.
  Amanda Lopez, Sanjay S. Patel, Julia T. Geyer, Joelle Racchumi, Amy Chadburn, Paul D. Simonson, Madhu M. Ouseph, Giorgio Inghirami, Nuria Mencia-Trinchant, Monica L. G...> ;Frontiers in Oncology. 2021 Aug 30
• 4 citations
  Adoptive immunotherapy with CB following chemotherapy for patients with refractory myeloid malignancy: chimerism and response
  Ok-Kyong Chaekal, Andromachi Scaradavou, Emeline Masson Frenet, Maria S. Albano, Melissa M. Cushing, Pinkal Desai, Ludy Dobrila, Usama Gergis, Danielle Guarneri, Jingm...> ;Blood Advances. 2020 Oct 27
• 15 citations
  Antibodies to the RNA binding protein heterogeneous nuclear ribonucleoprotein A1 contribute to neuronal cell loss in an animal model of multiple sclerosis
  Cole D. Libner, Hannah E. Salapa, Catherine Hutchinson, Sangmin Lee, Michael C. Levin> ;The Journal of Comparative Neurology. 2020 Jul 1
• Artifact-free CT images for electron beam therapy using a patient-specific non metallic shield.
  Jong In Park, Sangmin Lee, Il Han Kim, Sung-Joon Ye> ;Physica Medica. 2020 Jul 1
• 24 citations
  A Small-Molecule Pan-Id Antagonist Inhibits Pathologic Ocular Neovascularization.
  Paulina M. Wojnarowicz, Raquel Lima e Silva, Masayuki Ohnaka, Sang Bae Lee, Yvette Chin, Anita Kulukian, Sung Hee Chang, Bina Desai, Marta Garcia Escolano, Riddhi Shah...> ;Cell Reports. 2019 Oct 1
• Remote afterloading patient-specific brachytherapy with liquid radioisotope for irradiation of extensive scalp lesions: A Monte Carlo study.
  Dongmin Ryu, Jung In Kim, Sangmin Lee, Sung-Joon Ye, Jong Min Park> ;Medical Physics. 2019 Jul 1
• 4 citations
  Emerging drug profile: Krebs cycle and cancer: IDH mutations and therapeutic implications.
  Sangmin Lee, Arielle Urman, Pinkal Desai> ;Leukemia & Lymphoma. 2019 Apr 8
• 423 citations
  Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study.
  Andrew H. Wei, Stephen A. Strickland, Jing Zhou Hou, Walter Fiedler, Tara L. Lin, Roland B. Walter, Anoop K Enjeti, Ing Soo Tiong, Michael R. Savona, Sangmin Lee, Bren...> ;Journal of Clinical Oncology. 2019 Mar 20
• 3 citations
  Adoptive Immunotherapy with Cord Blood for the Treatment of Refractory Acute Myelogenous Leukemia: Feasibility, Safety, and Preliminary Outcomes
  Usama Gergis, Emeline Masson Frenet, Tsiporah B. Shore, Sebastian Mayer, Adrienne A. Phillips, Jingmei Hsu, Gail J. Roboz, Ellen K. Ritchie, Joseph M. Scandura, Sangmi...> ;Biology of Blood and Marrow Transplantation. 2019 Mar 1
• 6 citations
  Localization of near-infrared labeled antibodies to the central nervous system in experimental autoimmune encephalomyelitis
  Sangmin Lee, Hannah E. Salapa, Michael C. Levin> ;Plos One. 2019 Feb 15
• 351 citations
  Somatic mutations precede acute myeloid leukemia years before diagnosis.
  Pinkal Desai, Nuria Mencia-Trinchant, Oleksandr Savenkov, Michael S. Simon, Gloria Cheang, Sangmin Lee, Michael B. Samuel, Ellen K. Ritchie, Monica L. Guzman, Karla V....> ;Nature Medicine. 2018 Jul 1
• 5 citations
  MEASUREMENT OF NEUTRON AMBIENT DOSE EQUIVALENT IN PROTON RADIOTHERAPY WITH LINE-SCANNING AND WOBBLING MODE TREATMENT SYSTEM.
  Sangmin Lee, Chaeyeong Lee, Eun Hyuk Shin, Sungkoo Cho, Dae-Hyun Kim, Youngyih Han, Doo Ho Choi, Sung-Joon Ye, Jin Sung Kim> ;Radiation Protection Dosimetry. 2017 Dec 1
• 59 citations
  Minimal Residual Disease Monitoring of Acute Myeloid Leukemia by Massively Multiplex Digital PCR in Patients with NPM1 Mutations
  Nuria Mencia-Trinchant, Yang Hu, Maria Antonina Alas, Fatima Ali, Bas J. Wouters, Sangmin Lee, Ellen K. Ritchie, Pinkal Desai, Monica L. Guzman, Gail J. Roboz, Duane C...> ;The Journal of Molecular Diagnostics. 2017 Jul 1
• 10 citations
  Autoantibodies to heterogeneous nuclear ribonuclear protein A1 (hnRNPA1) cause altered ‘ribostasis’ and neurodegeneration; the legacy of HAM/TSP as a model of progress...
  Michael C. Levin, Sangmin Lee, Lidia A. Gardner, Yoojin Shin, Joshua N. Douglas, Hannah E. Salapa> ;Journal of Neuroimmunology. 2017 Mar 15
• 19 citations
  A role for Apolipoprotein A-I in the pathogenesis of multiple sclerosis.
  Lindsay Meyers, Joshua N. Douglas, Sangmin Lee, David D. Brand, Michael C. Levin, Lidia A. Gardner, Chassidy J. Groover> ;Journal of Neuroimmunology. 2014 Dec 15
• The Glycolytic Enzyme, GPI, Is a Functionally Conserved Modifier of Dopaminergic Neurodegeneration in Parkinson's Models.
  Knight, A. L.,Yan, X.,Hamamichi, S.,Ajjuri, R. R.,Mazzulli, J. R.,Zhang, M. W.,Daigle, J. G.,Zhang, S.,Borom, A. R.,Roberts, L. R.,Lee, S. K.,DeLeon, S. M.,Viollet-Dje...> ;Cell Metab.. 2014 Jun 03
• Join now to see all

Journal Articles

• Somatic Mutations Precede Acute Myeloid Leukemia Years Before Diagnosis  
  Sangmin Lee, Pinkal Desai, Gail J Roboz, Ellen K Ritchie, Nature

Abstracts/Posters

• Olutasidenib (FT-2102) Induces Rapid Remissions in Patients with IDH1-Mutant Myelodysplastic Syndrome: Results of Phase 1/2 Single Agent Treatment and Combination with...
  Sangmin Lee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• CPX-351 As First Intensive Therapy for Elderly Patients with AML
  Sangmin Lee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Antecedent Clonal Hematopoesis and Risk of and Mortality after Solid and Hematological Malignancies: Analyses from the Women's Health Initiative Study
  Sangmin Lee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Results from a Phase 1/2 Clinical Trial of Tagraxofusp (SL-401) in Patients with Intermediate, or High Risk, Relapsed/Refractory Myelofibrosis
  Sangmin Lee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• PTPN11 Mutated Acute Myeloid Leukemia (AML) Features an Abundant Epichaperome Network and Is Sensitive to the Epichaperome Inhibitor PU-H71
  Sangmin Lee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Phase II Trial of SGI-110 (Guadecitabine) in Philadelphia Negative Myeloproliferative Neoplasms
  Sangmin Lee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Olutasidenib (FT-2102), an IDH1m Inhibitor As a Single Agent or in Combination with Azacitidine, Induces Deep Clinical Responses with Mutation Clearance in Patients wi...
  Sangmin Lee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all

Lectures

• Eltanexor (KPT-8602), a Second-Generation Selective Inhibitor of Nuclear Export (SINE) Compound, in Patients with Higher-Risk Myelodysplastic Syndrome 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Changes in Gut Microbial Diversity and Correlations with Clinical Outcomes in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Receiving Intensive Chemotherapy 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Results from Ongoing Phase 1/2 Clinical Trial of Tagraxofusp (SL-401) in Patients with Intermediate or High Risk Relapsed/Refractory Myelofibrosis 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Results from Ongoing Phase 1/2 Clinical Trial of Tagraxofusp (SL-401) in Patients with Relapsed/Refractory Chronic Myelomonocytic Leukemia (CMML) 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Phase 1 Study of the IDH1m Inhibitor FT-2102 As a Single Agent in Patients with IDH1m Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• FT-2102, an IDH1m Inhibitor, in Combination with Azacitidine in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Ayndrome (MDS): Results from a Phase 1 Study 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Phase 1 First-in-Human Trial of AMV564, a Bivalent Bispecific (2x2) CD33/CD3 T-Cell Engager, in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML)Clinicall... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Does Presence of Persistent Molecular Mutations Matter in AML Patients Undergoing Allogeneic Stem Cell Transplant? 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Join now to see all